G04BD04 · Genito-urinary system and sex hormones
Kentera (previously Oxybutynin Nicobrand)
Indications
Symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in adult patients with unstable bladder.
Composition
- Active substance
- oxybutynin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Kentera (previously Oxybutynin Nicobrand)
- Active substance
- oxybutynin
- ATC code
- G04BD04
- Therapeutic area
- Urinary Incontinence, Urge
- Marketing authorisation holder
- Teva B.V.
- Status
- Authorised
- EU authorisation